Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia B Lewis

Showing results (11-20 of 93) with videos related to

Pageof 10
Sort By:
Current Hypertension Reports|September 2, 2003
Use of calcium antagonists in renal patients: therapeutic benefit or medical malpractice?Douglas A Nigbor, Julia B Lewis
The Medical Clinics of North America|January 8, 2013
Nonproteinuric diabetic nephropathy: when diabetics don't read the textbookJamie P Dwyer, Julia B Lewis
Journal of the American Society of Nephrology : JASN|April 22, 2004
ACE inhibitors versus angiotensin receptor blockers in diabetic nephropathy: is there a winner?Edmund J Lewis, Julia B Lewis
Current Hypertension Reports|November 6, 2004
Hypertension management: special considerations in chronic kidney disease patientsJames P Smith, Julia B Lewis
Advances in Chronic Kidney Disease|March 8, 2014
Optimizing blood pressure control in patients with nondiabetic glomerular diseaseKausik Umanath, Julia B Lewis, Jamie P Dwyer
The Journal of Urology|July 19, 2008
Association of gadolinium based magnetic resonance imaging contrast agents and nephrogenic systemic fibrosisGautam Bhave, Julia B Lewis, Sam S Chang
Circulation|August 8, 2022
"Dip" in eGFR: Stay the Course With SGLT-2 InhibitionKausik Umanath, Jeffrey M Testani, Julia B Lewis
Seminars in Dialysis|June 30, 2009
Evaluation of renal artery stenosis in dialysis patientsJamie P Dwyer, Barbara A Greco, Julia B Lewis
Diabetes Care|February 15, 2008
Microalbuminuria in type 2 diabetes and hypertension: a marker, treatment target, or innocent bystander?Seema Basi, Pierre Fesler, Albert Mimran, et al.
Expert Review of Endocrinology & Metabolism|February 9, 2019
Ferric citrate: a novel phosphate-binding agentKausik Umanath, Robert Niecestro, Julia B Lewis, et al.
Pageof 10

Showing results (11-20 of 93) with videos related to

Sort By:
Pageof 10
Current Hypertension Reports|September 2, 2003
Use of calcium antagonists in renal patients: therapeutic benefit or medical malpractice?Douglas A Nigbor, Julia B Lewis
The Medical Clinics of North America|January 8, 2013
Nonproteinuric diabetic nephropathy: when diabetics don't read the textbookJamie P Dwyer, Julia B Lewis
Journal of the American Society of Nephrology : JASN|April 22, 2004
ACE inhibitors versus angiotensin receptor blockers in diabetic nephropathy: is there a winner?Edmund J Lewis, Julia B Lewis
Current Hypertension Reports|November 6, 2004
Hypertension management: special considerations in chronic kidney disease patientsJames P Smith, Julia B Lewis
Advances in Chronic Kidney Disease|March 8, 2014
Optimizing blood pressure control in patients with nondiabetic glomerular diseaseKausik Umanath, Julia B Lewis, Jamie P Dwyer
The Journal of Urology|July 19, 2008
Association of gadolinium based magnetic resonance imaging contrast agents and nephrogenic systemic fibrosisGautam Bhave, Julia B Lewis, Sam S Chang
Circulation|August 8, 2022
"Dip" in eGFR: Stay the Course With SGLT-2 InhibitionKausik Umanath, Jeffrey M Testani, Julia B Lewis
Seminars in Dialysis|June 30, 2009
Evaluation of renal artery stenosis in dialysis patientsJamie P Dwyer, Barbara A Greco, Julia B Lewis
Diabetes Care|February 15, 2008
Microalbuminuria in type 2 diabetes and hypertension: a marker, treatment target, or innocent bystander?Seema Basi, Pierre Fesler, Albert Mimran, et al.
Expert Review of Endocrinology & Metabolism|February 9, 2019
Ferric citrate: a novel phosphate-binding agentKausik Umanath, Robert Niecestro, Julia B Lewis, et al.
Pageof 10